RIN2
Basic information
Region (hg38): 20:19757606-20002457
Links
Phenotypes
GenCC
Source: 
- RIN2 syndrome (Strong), mode of inheritance: AR
- RIN2 syndrome (Strong), mode of inheritance: AR
- RIN2 syndrome (Strong), mode of inheritance: AR
- RIN2 syndrome (Supportive), mode of inheritance: AR
- RIN2 syndrome (Definitive), mode of inheritance: AR
- RIN2 syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source: 
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References | 
|---|---|---|---|---|---|
| Macrocephaly, alopecia, cutis laxa, and scoliosis (MACS syndrome) | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Dental; Dermatologic; Musculoskeletal; Neurologic | 19631308; 20424861; 21431621; 23963297;24449201 | 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_provided (490 variants)
- Inborn_genetic_diseases (146 variants)
- not_specified (45 variants)
- RIN2-related_disorder (39 variants)
- RIN2_syndrome (25 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RIN2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000018993.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 147 | 154 | ||||
| missense | 266 | 19 | 291 | |||
| nonsense | 5 | |||||
| start loss | 0 | |||||
| frameshift | 17 | |||||
| splice donor/acceptor (+/-2bp) | 3 | |||||
| Total | 10 | 7 | 277 | 166 | 10 | 
Highest pathogenic variant AF is 0.00001968522
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| RIN2 | protein_coding | protein_coding | ENST00000255006 | 12 | 115937 | 
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p | 
|---|---|---|---|---|---|---|
| 0.000814 | 0.999 | 124622 | 0 | 18 | 124640 | 0.0000722 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.724 | 490 | 537 | 0.912 | 0.0000309 | 6122 | 
| Missense in Polyphen | 145 | 196.94 | 0.73628 | 2313 | ||
| Synonymous | 0.365 | 223 | 230 | 0.969 | 0.0000147 | 1864 | 
| Loss of Function | 3.65 | 12 | 35.4 | 0.339 | 0.00000179 | 442 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.0000942 | 0.0000941 | 
| Ashkenazi Jewish | 0.0000994 | 0.0000994 | 
| East Asian | 0.0000557 | 0.0000556 | 
| Finnish | 0.0000968 | 0.0000928 | 
| European (Non-Finnish) | 0.0000644 | 0.0000619 | 
| Middle Eastern | 0.0000557 | 0.0000556 | 
| South Asian | 0.000136 | 0.000131 | 
| Other | 0.000165 | 0.000165 | 
dbNSFP
Source: 
- Function
- FUNCTION: Ras effector protein. May function as an upstream activator and/or downstream effector for RAB5B in endocytic pathway. May function as a guanine nucleotide exchange (GEF) of RAB5B, required for activating the RAB5 proteins by exchanging bound GDP for free GTP. {ECO:0000269|PubMed:11733506}.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Rab regulation of trafficking;Posttranslational regulation of adherens junction stability and dissassembly;RAB GEFs exchange GTP for GDP on RABs;Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) (Consensus) 
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.602
- rvis_EVS
- 0.52
- rvis_percentile_EVS
- 80.4
Haploinsufficiency Scores
- pHI
- 0.196
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.493
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.584
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium | 
| Primary Immunodeficiency | Medium | Medium | Medium | 
| Cancer | Medium | Medium | Medium | 
Mouse Genome Informatics
- Gene name
- Rin2
- Phenotype
Gene ontology
- Biological process
- endocytosis;small GTPase mediated signal transduction;positive regulation of GTPase activity
- Cellular component
- cellular_component;cytosol
- Molecular function
- GTPase activator activity;Rab guanyl-nucleotide exchange factor activity;GTPase regulator activity